Suchergebnisse - "Zhang, Puhong"

PubPharm (9)

1

Effectiveness and safety of basal insulin therapy in type 2 diabetes mellitus patients with or without metformin observed in a national cohort in China

enthalten in: BMC endocrine disorders | 2022

von Zhang, P. | Chen, M. | Zhang, H. | +7

2

Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP) : A cluster randomized trial

enthalten in: PLoS medicine | 2021

von Jia, W. | Zhang, P. | Zhu, D. | +5

3

Factors associated with glycemic control in type 1 diabetes patients in China : A cross-sectional study

enthalten in: Journal of diabetes investigation | 2020

von Huo, L. | Deng, W. | Shaw, J. | +6

4

Patient characteristics and 6-month dose of basal insulin associated with HbA1c achievement <7.0% in Chinese people with type 2 diabetes : results from the Observational Registry of Basal Insulin Treatment (ORBIT)

enthalten in: Journal of diabetes | 2020

von Gao, L. | Zhang, P. | Weng, J. | +13

5

Clinical characteristics of type 2 diabetes patients with discordance between HbA1c and fasting plasma glucose in the real world : An analysis of the ORBIT study

enthalten in: Diabetes/metabolism research and reviews | 2018

von Shu, H. | Lu, J. | Zhang, P. | +5

6

Observational Registry of Basal Insulin Treatment in Patients with Type 2 Diabetes in China : Safety and Hypoglycemia Predictors

enthalten in: Diabetes technology & therapeutics | 2017

von Zhang, T. | Ji, L. | Gao, Y. | +7

7

Comparative effectiveness and safety of different basal insulins in a real-world setting

enthalten in: Diabetes, obesity & metabolism | 2017

von Ji, L. | Zhang, P. | Zhu, D. | +15

8

Observational Registry of Basal Insulin Treatment (ORBIT) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs : Real-life use of basal insulin in China

enthalten in: Diabetes, obesity & metabolism | 2017

von Ji, L. | Zhang, P. | Zhu, D. | +13

9

Observational Registry of Basal Insulin Treatment (ORBIT) in Patients with Type 2 Diabetes Uncontrolled by Oral Hypoglycemic Agents in China--Study Design and Baseline Characteristics

enthalten in: Diabetes technology & therapeutics | 2015

von Ji, L. | Zhang, P. | Weng, J. | +13

1
[1]